Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study identifies USP15 as a critical protein in cancer

After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.

20 Feb 2012

Remote controlled microchip successfully delivers drug in early clinical trial

Researchers have developed a new microchip implant device that can deliver bone-building drugs to seven osteoporosis patients. The microchips worked inside patients as drug-delivering pacemakers, following a prescription plan sent by radio signal.

18 Feb 2012

OICR launches Phase III Active Surveillance Magnetic Resonance Imaging Study Trial

Dr. Nicole Onetto, Deputy Director and Chief Scientific Officer of the Ontario Institute for Cancer Research (OICR), today announced the launch of an innovative Phase III clinical trial that aims to determine whether multi-parametric magnetic resonance imaging (MRI) coupled with transrectal ultrasound (TRUS) guided biopsy (called fusion technology) can accurately identify men with prostate cancer who are at risk of developing aggressive disease.

18 Feb 2012

Elekta's Fraxion integrates all proven cranial immobilization options in a single solution

The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.

From Elekta 18 Feb 2012

Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use

Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

18 Feb 2012

Novel feeding device may decrease risk of FTT in newborns with congenital heart defects

A novel feeding device developed at the University of Pennsylvania School of Nursing may decrease the risk of failure to thrive (FTT), which currently affects half of all newborns with congenital heart defects even after their surgical lesions are corrected.

18 Feb 2012

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that, as anticipated, on February 15, 2012, the Company was notified by The NASDAQ Stock Market that because the Company has not regained compliance with the $1.00 minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before a NASDAQ Hearings Panel.

18 Feb 2012

EMA CHMP recommends CTI's Pixuvri for conditional approval

Cell Therapeutics, Inc. announced today that Pixuvri has been granted a positive opinion for conditional approval from the European Medicines Agency's Committee for Medicinal Products for Human Use.

18 Feb 2012

Evergreen receives Advanced Certification in Inpatient Diabetes from The Joint Commission

Evergreen Healthcare has earned Advanced Certification in Inpatient Diabetes from The Joint Commission for its comprehensive diabetes treatment program, establishing it as Washington state's only program to currently hold the distinction.

18 Feb 2012

Aptuit sells Clinical Trials Supply business to Catalent Pharma Solutions

Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012. Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.

18 Feb 2012

Adherence rates for hypertension medications lower among African-American patients

Racial disparities in hypertension control account for nearly 8,000 preventable deaths annually among African-Americans, making increased blood pressure control among African-Americans a "compelling goal," reported Lisa M. Lewis, PhD, RN, of the University of Pennsylvania School of Nursing in the Journal of Cardiovascular Nursing.

18 Feb 2012

UH's Eye Institute receives $5M Elisabeth Severance Prentiss Foundation gift

The Elisabeth Severance Prentiss Foundation again has demonstrated its commitment to University Hospitals (UH) with a $5 million gift for the Eye Institute. The gift will honor the late Benjamin L. Millikin, MD, husband of Julia Severance and the grandfather of Prentiss Foundation trustee Elisabeth Alexander.

18 Feb 2012

Asuragen introduces miRInform test for diagnosis of pancreatic ductal adenocarcinoma

Asuragen, Inc. announced today the immediate availability of the miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. miRInform® Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. The test evaluates expression levels of seven miRNAs in Fine Needle Aspirate (FNA) specimens of pancreatic masses.

17 Feb 2012

Dance against diabetes

Heart disease is the leading cause of death among people with diabetes. In a unique upbeat program, professor and nurse practitioner Terri Lipman, PhD, CRNP, of the University of Pennsylvania School of Nursing, encourages children to ward off diabetes and hip-hop their way to good health.

17 Feb 2012

Lung cancer patients with severe COPD can benefit from SBRT

Stereotactic body radiotherapy (SBRT) provides better overall survival rates than surgery for lung cancer patients with severe chronic obstructive pulmonary disease (COPD), a disease commonly associated with lung cancer, according to a study in the upcoming March issue of the International Journal of Radiation, Oncology, Biology, Physics, the official scientific journal of the American Society for Radiation Oncology.

17 Feb 2012

New potential strategy for KRAS-mutant colon cancers

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted treatments.

17 Feb 2012

LUMC named one of the nation's top hospitals in cancer treatment

Loyola University Medical Center has been named one of the nation's top hospitals in cancer research, prevention, treatment and education by Becker's Hospital Review.

17 Feb 2012

Four new drugs can extend survival and prognosis of prostate cancer

After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease, a leading Colorado prostate cancer expert says.

17 Feb 2012

Nordion celebrates first anniversary of market launch of TheraSphere

Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.

17 Feb 2012

Shortage looming, drug maker agrees to release emergency supplies of kids' cancer drug

A shortage of a drug used to treat children's cancer seems to have been averted for a time as the Food and Drug Administration says it reached an agreement with the drug supplier to release emergency supplies. Elsewhere, rules sometimes force hospitals to throw away scarce drugs.

17 Feb 2012

Oncology News and Research

Further Reading

Study identifies USP15 as a critical protein in cancer

Remote controlled microchip successfully delivers drug in early clinical trial

OICR launches Phase III Active Surveillance Magnetic Resonance Imaging Study Trial

Elekta's Fraxion integrates all proven cranial immobilization options in a single solution

Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use

Novel feeding device may decrease risk of FTT in newborns with congenital heart defects

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

EMA CHMP recommends CTI's Pixuvri for conditional approval

Evergreen receives Advanced Certification in Inpatient Diabetes from The Joint Commission

Aptuit sells Clinical Trials Supply business to Catalent Pharma Solutions

Adherence rates for hypertension medications lower among African-American patients

UH's Eye Institute receives $5M Elisabeth Severance Prentiss Foundation gift

Asuragen introduces miRInform test for diagnosis of pancreatic ductal adenocarcinoma

Dance against diabetes

Lung cancer patients with severe COPD can benefit from SBRT

New potential strategy for KRAS-mutant colon cancers

LUMC named one of the nation's top hospitals in cancer treatment

Four new drugs can extend survival and prognosis of prostate cancer

Nordion celebrates first anniversary of market launch of TheraSphere

Shortage looming, drug maker agrees to release emergency supplies of kids' cancer drug

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News